NASDAQ:VNDA

Vanda Pharmaceuticals Stock Insider Trading

etoro logo Buy VNDA
*Your capital is at risk
$6.09
-0.0400 (-0.653%)
At Close: Jun 03, 2026

Vanda Pharmaceuticals Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be negative at -10.63. In total, the insiders bought 4.18M and sold 783.36K VNDA shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power

(Last 100 transactions)
-10.63
Buy 4.18M shares
Sell 783.36K shares
77% Buy Activity
Negligible or No Correlation
Sell Signal Low Confidence
Mar 02, 2026

Analysis Breakdown:

  • Confidence increased due to high data reliability score of 100.

Historical Insider Trades

Date Type Person Role Amount
Feb 26, 2025
Buy
Common Stock
P-Purchase
Polymeropoulos Mihael Hristos
President And CEO
CEO / President 5 000
Value: $23.8K
Feb 26, 2025
Buy
Common Stock
P-Purchase
Polymeropoulos Mihael Hristos
President And CEO
CEO / President 5 000
Value: $23.8K
Feb 26, 2025
Buy
Common Stock
P-Purchase
Polymeropoulos Mihael Hristos
President And CEO
CEO / President 5 000
Value: $23.9K
Feb 25, 2025
Buy
Common Stock
P-Purchase
Polymeropoulos Mihael Hristos
President And CEO
CEO / President 10 000
Value: $44.6K
Feb 25, 2025
Buy
Common Stock
P-Purchase
Polymeropoulos Mihael Hristos
President And CEO
CEO / President 10 000
Value: $44.6K
Feb 21, 2025
Buy
Common Stock
P-Purchase
Moran Kevin Patrick
SVP, CFO & Treasurer
C-Suite Officer 2 000
Value: $9K
Feb 21, 2025
Buy
Common Stock
P-Purchase
Moran Kevin Patrick
SVP, CFO & Treasurer
C-Suite Officer 2 000
Value: $9K
Feb 18, 2025
Buy
Common Stock
A-Award
Wijkstrom Joakim
SVP, Chief Marketing Officer
Officer 125 000
Value: $557.5K
Feb 18, 2025
Buy
Common Stock
A-Award
Polymeropoulos Mihael Hristos
President And CEO
CEO / President 450 000
Value: $2.01M
Feb 18, 2025
Buy
Common Stock
A-Award
Moran Kevin Patrick
SVP, CFO & Treasurer
C-Suite Officer 125 000
Value: $557.5K
Feb 18, 2025
Buy
Common Stock
A-Award
Birznieks Gunther
SVP, Business Development
Officer 125 000
Value: $557.5K
Feb 18, 2025
Buy
Common Stock
A-Award
Williams Timothy
SVP & General Counsel
Officer 125 000
Value: $557.5K
Feb 18, 2025
Buy
Common Stock
A-Award
Williams Timothy
SVP & General Counsel
Officer 125 000
Value: $557.5K
Feb 18, 2025
Buy
Common Stock
A-Award
Birznieks Gunther
SVP, Business Development
Officer 125 000
Value: $557.5K
Feb 18, 2025
Buy
Common Stock
A-Award
Moran Kevin Patrick
SVP, CFO & Treasurer
C-Suite Officer 125 000
Value: $557.5K
Feb 18, 2025
Buy
Common Stock
A-Award
Polymeropoulos Mihael Hristos
President And CEO
CEO / President 450 000
Value: $2.01M
Feb 18, 2025
Buy
Common Stock
A-Award
Wijkstrom Joakim
SVP, Chief Marketing Officer
Officer 125 000
Value: $557.5K
Nov 14, 2024
Sell
Common Stock
S-Sale
Mitchell Stephen Ray
Director
Director 5 000
Value: $25.9K
Nov 14, 2024
Sell
Common Stock
S-Sale
Mitchell Stephen Ray
Director
Director 5 000
Value: $25.9K
Jul 29, 2024
Sell
Common Stock
S-Sale
Moran Kevin Patrick
SVP, CFO & Treasurer
C-Suite Officer 2 251
Value: $13.3K
Jul 29, 2024
Sell
Common Stock
S-Sale
Moran Kevin Patrick
SVP, CFO & Treasurer
C-Suite Officer 2 251
Value: $13.3K
May 22, 2024
Buy
Common Stock
A-Award
Chrousos Phaedra
Director
Director 21 887
Value: $0
May 22, 2024
Buy
Stock Option (right to buy)
A-Award
Chrousos Phaedra
Director
Director 40 202
Value: $206.6K
May 22, 2024
Buy
Stock Option (right to buy)
A-Award
Chrousos Phaedra
Director
Director 40 202
Value: $206.6K
May 22, 2024
Buy
Common Stock
A-Award
Chrousos Phaedra
Director
Director 21 887
Value: $0

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

Click to get the best stock tips daily for free!
ABOUT VANDA PHARMACEUTICALS INC.
Vanda Pharmaceuticals
Vanda Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of therapies to address high unmet medical needs. The company's marketed products include HETLIOZ for the treatment of non-24-hour sleep-wake disorders; and Fanapt oral tablets for the treatment of schizophrenia. Its products under development include HETLIOZ (tasimelteon) for the treatment of jet lag disorder, smith-magenis syndrome, pediatr...
GOLDEN STAR
Ticker Change Signal Date
RUN
$12.83
18.86% May 06
GLBE
$31.61
5.35% May 05
SAP
$172.39
10.69% May 05
W
WCLD
$27.34
27.18% Apr 29
ADBE
$243.57
7.61% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE